| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.2 |